Quanterix Corporation (QTRX)
NASDAQ (NMS) NASDAQ (NMS) Primary 
Down 24.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Quanterix (QTRX)
Quanterix (QTRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Quanterix Corporation (QTRX) Q2 2025 Earnings Call Transcript
Quanterix Corporation (NASDAQ:QTRX ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 AM ET Company Participants Joshua Young - Corporate Participant Masoud Toloue - President, CEO & Director Vandana Sriram - CFO & Treasurer Conference Call Participants Michael Aaron Cherny - Leerink Partners LLC, Research Division Thomas DeBourcy - Nephron Research Operator Good day, everyone, and thank you for standing by. My name is [ RJ ], and I will be your conference operator today.
Quanterix Corporation (QTRX) Q1 2025 Earnings Call Transcript
Quanterix Corporation (NASDAQ:QTRX ) Q1 2025 Earnings Conference Call May 12, 2025 4:30 PM ET Company Participants Joshua Young - Head, IR Masoud Toloue - President and CEO Vandana Sriram - CFO Conference Call Participants Kyle Mikson - Canaccord Sung Ji Nam - Scotiabank Puneet Souda - Leerink Partners Dan Brennan - TD Cowen Operator Ladies and gentlemen, thank you for standing by. My name is Desiree and I will be your conference operator today.
Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates
Quanterix Corporation (QTRX) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.69. This compares to loss of $0.26 per share a year ago.
Quanterix Corporation (QTRX) Q4 2024 Earnings Call Transcript
Quanterix Corporation (NASDAQ:QTRX ) Q4 2024 Earnings Conference Call March 17, 2025 4:30 PM ET Company Participants Joshua Young - Head of IR Masoud Toloue - President and CEO Vandana Sriram - CFO Conference Call Participants Matt Sykes - Goldman Sachs Kyle Mikson - Canaccord Puneet Souda - Leerink Partners Dan Brennan - TD Cowen Sung Ji Nam - Scotiabank Operator Thank you for standing by. My name is Kathleen and I will be your conference operator today.
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Quanterix Corporation For Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / January 15, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Quanterix Corporation Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / January 14, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Quanterix Corporation For Securities Fraud
LOS ANGELES, CA / ACCESSWIRE / January 13, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Quanterix price target lowered by $4 at TD Cowen, here's why
Quanterix + Akoya Biosciences +0.39 (+14.72%)
Quanterix Corporation Is Being Investigated For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / January 12, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quanterix Corporation - QTRX
NEW YORK, NY / ACCESSWIRE / January 12, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Quanterix Corporation Investors to Inquire About Securities Class Action Investigation – QTRX
NEW YORK, NY / ACCESSWIRE / January 11, 2025 / Rosen Law Firm PA WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Quanterix Corporation (NASDAQ:QTRX) resulting from allegations that Quanterix may have issued materially misleading business information to the investing public. SO WHAT: If you purchasedQuanterixsecurities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
